Dan-Qin Sun

Mar 11, 2025 | digitalcommons.library.tmc.edu | Christopher Byrne |Dan-Qin Sun |Giovanni Targher |David Wheeler

BACKGROUND: With the rising global prevalence of fatty liver disease related to metabolic dysfunction, the association of this common liver condition with chronic kidney disease (CKD) has become increasingly evident. In 2020, the more inclusive term metabolic dysfunction-associated fatty liver disease (MAFLD) was proposed to replace the term non-alcoholic fatty liver disease (NAFLD).